Purdue Pharma successfully resolves Hatch-Waxman patent infringement claims against Ascent related to OxyContin®
Clients Purdue Pharma L.P.
Jones Day successfully represented Purdue Pharma L.P. in related Hatch-Waxman patent infringement actions against defendant Ascent Pharmaceuticals, Inc., pertaining to the submission of an Abbreviated New Drug Application to the FDA seeking approval of a generic version of OxyContin®. Purdue came to a successful resolution of the dispute through settlement.
Purdue Pharma LP et al. v. Ascent Pharmaceuticals, Inc., Nos. 1-18-cv-00083, -00855 (D. Del.)